ECI Pharmaceuticals is a specialty pharmaceutical company with capabilities that include complete R&D services, analytical and formulation development, ANDA/NDA product submissions and U.S.-based manufacturing of tablets, capsules and liquids.
View Top Employees from ECI Pharmaceuticals, LLCWebsite | http://www.ecipharma.com |
Revenue | $15 million |
Funding | $1 million |
Employees | 12 (12 on RocketReach) |
Founded | 2010 |
Address | 5311 NW 35th Ter, Fort Lauderdale, Florida 33309, US |
Phone | (954) 486-8181 |
Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
Industry | Pharmaceuticals, Drug Stores & Pharmacies, R&D, Retail, Regulatory Services, Product Development, Manufacturing, Laboratory |
Competitors | Amneal Pharmaceuticals, Catalent Pharma Solutions, Lonza, PHARMACEUTICAL MANAGEMENT SERVICES LIMITED, Xcelience (Acquired by Capsugel) |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular ECI Pharmaceuticals, LLC employee's phone or email?
The ECI Pharmaceuticals, LLC annual revenue was $15 million in 2024.
Felipe Garay is the Director Of Operations and Manufacturing of ECI Pharmaceuticals, LLC.
12 people are employed at ECI Pharmaceuticals, LLC.
ECI Pharmaceuticals, LLC is based in Fort Lauderdale, Florida.
The NAICS codes for ECI Pharmaceuticals, LLC are [32, 325, 3254, 32541].
The SIC codes for ECI Pharmaceuticals, LLC are [283, 28].